Published: Guidance, quality standards and advice

Skip to filters Skip to results

Showing 651 to 675 of 797

Sort by

Guidance programme: Technology appraisal guidanceRemove Guidance programme: Technology appraisal guidance filter

Published guidance, NICE advice and quality standards
Title	Reference number	Published	Last updated
Canagliflozin in combination therapy for treating type 2 diabetes	TA315	25 June 2014	25 June 2014
Implantable cardioverter defibrillators and cardiac resynchronisation therapy for arrhythmias and heart failure	TA314	25 June 2014	25 June 2014
Teriflunomide for treating relapsing–remitting multiple sclerosis	TA303	22 January 2014	1 June 2014
Afatinib for treating epidermal growth factor receptor mutation-positive locally advanced or metastatic non-small-cell lung cancer	TA310	23 April 2014	23 April 2014
Bortezomib for induction therapy in multiple myeloma before high-dose chemotherapy and autologous stem cell transplantation	TA311	23 April 2014	23 April 2014
Rituximab in combination with glucocorticoids for treating anti-neutrophil cytoplasmic antibody-associated vasculitis	TA308	26 March 2014	26 March 2014
Aflibercept in combination with irinotecan and fluorouracil-based therapy for treating metastatic colorectal cancer that has progressed following prior oxaliplatin-based chemotherapy	TA307	25 March 2014	25 March 2014
Total hip replacement and resurfacing arthroplasty for end-stage arthritis of the hip	TA304	26 February 2014	26 February 2014
Aflibercept for treating visual impairment caused by macular oedema secondary to central retinal vein occlusion	TA305	26 February 2014	26 February 2014
Pixantrone monotherapy for treating multiply relapsed or refractory aggressive non-Hodgkin's B‑cell lymphoma	TA306	26 February 2014	26 February 2014
Peginterferon alfa and ribavirin for treating chronic hepatitis C in children and young people	TA300	27 November 2013	27 November 2013
Canakinumab for treating systemic juvenile idiopathic arthritis (terminated appraisal)	TA302	27 November 2013	27 November 2013
Peginterferon alfa and ribavirin for the treatment of mild chronic hepatitis C	TA106	23 August 2006	27 November 2013
Interferon alfa (pegylated and non-pegylated) and ribavirin for the treatment of chronic hepatitis C	TA75	28 January 2004	27 November 2013
Pazopanib for the first-line treatment of advanced renal cell carcinoma	TA215	23 February 2011	1 August 2013
Aripiprazole for treating moderate to severe manic episodes in adolescents with bipolar I disorder	TA292	24 July 2013	24 July 2013
Aflibercept solution for injection for treating wet age‑related macular degeneration	TA294	24 July 2013	24 July 2013
Rivaroxaban for treating pulmonary embolism and preventing recurrent venous thromboembolism	TA287	26 June 2013	26 June 2013
Mirabegron for treating symptoms of overactive bladder	TA290	26 June 2013	26 June 2013
Bevacizumab in combination with paclitaxel and carboplatin for first-line treatment of advanced ovarian cancer	TA284	22 May 2013	22 May 2013
Bevacizumab in combination with gemcitabine and carboplatin for treating the first recurrence of platinum-sensitive advanced ovarian cancer	TA285	22 May 2013	22 May 2013
Loxapine inhalation for treating acute agitation and disturbed behaviours associated with schizophrenia and bipolar disorder (terminated appraisal)	TA286	22 May 2013	22 May 2013
Omalizumab for treating severe persistent allergic asthma	TA278	24 April 2013	24 April 2013
Percutaneous vertebroplasty and percutaneous balloon kyphoplasty for treating osteoporotic vertebral compression fractures	TA279	24 April 2013	24 April 2013
Colistimethate sodium and tobramycin dry powders for inhalation for treating pseudomonas lung infection in cystic fibrosis	TA276	27 March 2013	27 March 2013

Results per page

10
25
50
All